These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2422865)
21. Effects of dietary linoleic acid and gamma linolenic acid on platelets of patients with multiple sclerosis. Mcgregor L; Smith AD; Sidey M; Belin J; Zilkha KJ; McGregor JL Acta Neurol Scand; 1989 Jul; 80(1):23-7. PubMed ID: 2782038 [TBL] [Abstract][Full Text] [Related]
22. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides in multiple sclerosis. Frick E J Neurol Sci; 1982; 57(1):55-66. PubMed ID: 6185643 [TBL] [Abstract][Full Text] [Related]
23. Response to platelet-activating factor of platelets from patients with multiple sclerosis. Khan SN; Belin J; Smith AD; Sidey M; Zilkha KJ Acta Neurol Scand; 1985 Mar; 71(3):212-20. PubMed ID: 3993327 [TBL] [Abstract][Full Text] [Related]
24. ADP-induced platelet aggregation in young female survivors of acute myocardial infarction and their female controls. Vilén L; Johansson S; Kutti J; Cronberg S; Vedin A; Wilhelmsson C Acta Med Scand; 1985; 217(1):9-13. PubMed ID: 3976437 [TBL] [Abstract][Full Text] [Related]
25. [Effect of paclitaxel on platelet aggregation induced by adenosine diphosphate in vitro]. Zhang S; Sun CL; Nie H Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):928-30. PubMed ID: 24490504 [TBL] [Abstract][Full Text] [Related]
26. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association. Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386 [TBL] [Abstract][Full Text] [Related]
27. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390 [TBL] [Abstract][Full Text] [Related]
28. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815 [TBL] [Abstract][Full Text] [Related]
29. Increased platelet aggregation induced by glucagon administration. Proctor SJ; Davies TF; Oxley A; Jones P; Heath A Acta Haematol; 1980; 64(1):6-11. PubMed ID: 6774577 [TBL] [Abstract][Full Text] [Related]
30. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866 [TBL] [Abstract][Full Text] [Related]
31. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111 [TBL] [Abstract][Full Text] [Related]
32. Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate). Cusack NJ; Hourani SM Br J Pharmacol; 1982 Feb; 75(2):257-9. PubMed ID: 6892270 [TBL] [Abstract][Full Text] [Related]
33. Halothane stimulates the aggregation of platelets of both normal individuals and those susceptible to malignant hyperthermia. Gerrard JM; Duncan PG; Koshyk SA; Glover SM; McCrea JM Br J Anaesth; 1983 Dec; 55(12):1249-57. PubMed ID: 6652014 [TBL] [Abstract][Full Text] [Related]
34. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis. Greer JM; Csurhes PA; Cameron KD; McCombe PA; Good MF; Pender MP Brain; 1997 Aug; 120 ( Pt 8)():1447-60. PubMed ID: 9278634 [TBL] [Abstract][Full Text] [Related]
35. Plasma citrulline levels are increased in patients with multiple sclerosis. Vande Vyver M; Beelen R; De Keyser J; Nagels G; Van Binst AM; Verborgh C; D'haeseleer M J Neurol Sci; 2018 Apr; 387():174-178. PubMed ID: 29571859 [TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a. Matà S; Lolli F; Söderström M; Pinto F; Link H Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693 [TBL] [Abstract][Full Text] [Related]
37. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline. Michal F; Motamed M Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669 [TBL] [Abstract][Full Text] [Related]
38. Effects of cefonicid on platelet aggregation. Cazzola M; Santangelo G; Paizis G; Matera C; Rossi F Drugs Exp Clin Res; 1991; 17(2):105-8. PubMed ID: 1864223 [TBL] [Abstract][Full Text] [Related]
39. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen. Ts'ao C Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732 [TBL] [Abstract][Full Text] [Related]
40. Binding properties of cerebrospinal fluid IgG in multiple sclerosis and other neurological diseases. Page N; Perruisseau G; Steck AJ J Neurol Sci; 1983 Jul; 60(1):23-30. PubMed ID: 6192219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]